Sigma-Aldrich Corp (SIAL)

139.76
0.05 0.04
Prev Close 139.81
Open 139.82
Day Low/High 139.74 / 139.90
52 Wk Low/High 135.33 / 140.03
Volume 6.25M
Avg Volume 1.26M
Exchange
Shares Outstanding 119.99M
Market Cap 16.78B
EPS 4.20
Div & Yield 0.92 (0.70%)
Movers Roundup: KBR, Sangamo Biosciences

Movers Roundup: KBR, Sangamo Biosciences

Movers roundup: KBR gains as analyst sees moves into energy, Sangamo Biosciences rises

Sangamo Rises Further On Sigma-Aldrich Study Plan

Sangamo Rises Further On Sigma-Aldrich Study Plan

Sangamo Biosciences sustains Monday gains as analyst looks at Sigma-Aldrich licensing pact

Under the Radar: Balchem's Pint-Sized Power

Under the Radar: Balchem's Pint-Sized Power

Balchem operates on the edges of food science, enabling the small company to corner certain markets.

Options: Traders Bet on Jefferies Rally

Options: Traders Bet on Jefferies Rally

Options investors are betting that Jefferies shares will rise and Cemex shares will stall, OptionMonster says.

Traders See Upside to Sigma-Aldrich

Traders See Upside to Sigma-Aldrich

The average daily total for all Sigma-Aldrich options is 210 contracts, but calls alone totaled 4,474 Tuesday vs. just 58 puts.

Sigma-Aldrich 1Q Profit Dips Slightly

Sigma-Aldrich's 1st-quarter profit dips slightly as stronger dollar cuts into overseas sales

Sigma-Aldrich CEO Got $4 Million In Compensation

Sigma-Aldrich says CEO Nagarkatti received about $4 million in compensation package in 2008

Three Big Buys and Sells

Here are three stocks to dump and three to jump into.

STOCK PICKS: Top 5 Mid-Caps for Sept. 4

Circor International, Sigma-Aldrich, American Ecology, Amphenol and Ameron International make the list.

STOCK PICKS: Top 5 Mid-Caps for Aug. 28

Donaldson, Amphenol, Sigma-Aldrich, FMC and Flowserve make the list.

STOCK PICKS: Top 5 Mid-Cap for Aug. 21

CIRCOR International, Amphenol, Sigma-Aldrich, American Ecology and Airgas make the list.

Top Five Mid-Cap Stocks: Ametek

Ametek, Berry Petroleum, Energen, Flowserve and Sigma-Aldrich are all on top.

Top Five Mid-Cap Stocks

Flowserve, Sigma-Aldrich, Bucyrus, Steel Dynamics and Cabot Oil & Gas are all on top.

Top Five Mid-Cap Stocks

Flowserve, Sigma-Aldrich, Steel Dynamics, FMC and Badger Meter are all on top.

Top Five Mid-Caps: April 3

Flowserve, Sigma-Aldrich, C.H. Robinson, Circor and Cabot Oil & Gas are all on top.

The Real Winners of Drug Experimentation

The companies that supply the tools needed for pharma research and development often profit no matter the success of a drug trial.

Top Five Mid-Cap Stocks: March 27

Flowserve, Sigma-Aldrich, Circor, Ameron and C.H. Robinson are all on top.

Low Volume Bounce Coming Into Play

Many stocks have not been able to find buying interest since short-sellers covered their positions last week.

Top Five Mid-Cap Stocks: March 20

Sigma-Aldrich, Flowserve, Bucyrus, Ameron and Pharmaceutical Product Development are all on top.

Top Five Mid-Cap Stocks

Sigma-Aldrich, Flowserve, Pharmaceutical Product Development, Lindsay and Helmerich & Payne are all on top.

Risk Remains High

The day after a Fed decision often reverses; plus, players are positioning ahead of Friday's labor report.

You Ask, Cramer Answers

Jim Cramer answers questions on Sigma-Aldrich, Hershey and more.

Top Five Mid-Cap Stocks

Triumph Group, Ambassadors group in the lead.

Top Five Mid-Cap Stocks

Triumph Group, Ambassadors Group lead the charge.

Tuesday's Late Winners & Losers

Innovo Group is surging.

Top Five Mid-Cap Stocks

Magellan Midstream and Belden CDT lead off this week's list of top-rated companies.

Stockpickr: The Top Dividend 'Aristocrats'

These stocks offer high yield, consistent growth and safety.

Cramer's 'Mad Money' Recap: Get In the GameStop

Cramer's 'Mad Money' Recap: Get In the GameStop

Even though EA has the wildly popular Madden NFL game, GameStop is better positioned, says Cramer.

Sigma-Aldrich Names CEO

Sigma-Aldrich Names CEO

'Jai Nagarkatti is a very seasoned,' the chairman notes.

Sigma-Aldrich in Oxford Biomedica Link

The company will commercialize the gene therapy outfit's LentiVector product for research.